RE: Government's new weapon against Covid199 Sep 2020 10:52
"Hypermarlin, I think you're right in the approach.
I don't know where AVCT are in the development/validation cycle though."
Way behind. The reality is that they're not even at validation stage, or near CE marking for professional use. I've got some AVCT shares but I don't think they'll boom as much as ODX. There seems to be a lot of hype around the AVCT test, in part based on its inclusion in the CONDOR process, but little real concrete milestones. They also don't have the range that ODX has.
One of the things I've liked about ODX from the beginning is the lack of hype from the management team. Instead we've had a realistic timetable - and, where they've been in control of that timetable, they've quietly and consistently delivered.